Butylscopolamine

This tender concerns the procurement of Butylscopolamine, specifically a solution for injection. The pharmaceutical code is A03BB01. The product is supplied in 1 ml ampoules, with each ampoule containing 20 mg of Butylscopolamine. The total quantity required is 4800 ampoules. Butylscopolamine is an anticholinergic medication used to relieve spasms of the smooth muscle in the gastrointestinal tract, biliary system, and urinary tract. It is commonly prescribed for conditions such as abdominal pain, cramps, and irritable bowel syndrome. The tender is seeking a supplier for this essential medication, likely for use within a healthcare setting, such as a hospital or clinic. Key requirements would typically include adherence to pharmaceutical quality standards, Good Manufacturing Practices (GMP), and potentially specific packaging and delivery timelines. The tender is open to eligible suppliers who can meet the specified quantity and quality demands for this injectable pharmaceutical product. Further details regarding the tendering process, submission deadlines, and evaluation criteria would be available in the full tender documentation.

This is a supplies contract in the health and medical services sector, with a focus on Primary Healthcare, Hospitals and Pharmaceuticals. Located in Bulgaria, Europe, this opportunity is open to firms and consortiums, with an estimated budget of BGN 2,592.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.